Rigidity of human α-fetoprotein tertiary structure is under ligand control

Biochemistry

Volumn 36, Issue 44, 1997, Pages 13638-13645

  Uversky, Vladimir N ^a   Narizhneva, Natalya V ^a   Ivanova, Tatyana V ^a   Tomashevski, Andrey Yu ^b  

^a INSTITUTE OF PROTEIN RESEARCH   (Russian Federation)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HUMAN SERUM ALBUMIN; UREA;

ARTICLE; CIRCULAR DICHROISM; FLUORESCENCE SPECTROSCOPY; HUMAN; MICROCALORIMETRY; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; RIGIDITY; THERMODYNAMICS;

ALPHA-FETOPROTEINS; CIRCULAR DICHROISM; HUMANS; LIGANDS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; UREA;

EID: 0030780359     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi970332p     Document Type: Article

References (56)

1. Abelev, G. I. (1970) Adv. Cancer Res. 14, 295-358.
2. Adler, A. J., Greenfield, N. J., & Fasman, G. D. (1973) Methods Enzymol. 27, 675-735.
3. Alpert, E., Drysdale, J. W., & Isselbacher, K. J. (1973) Ann. N.Y. Acad. Sci. 209, 387-391.
4. Aoyagi, Y., Ikenaka, T., & Ichida, F. (1978) Cancer Res. 38, 3483-3486.
5. Bradshaw, R. A., Shearer, W. T., & Gurd, F. R. N. (1968) J. Biol. Chem. 243, 3817-3825.
6. Brock, D. J., Scrimgeour, J. B., & Nelson, M. M. (1975) Clin. Genet. 7, 163-169.
7. Brown, J. R. (1975) Fed. Proc., Fed. Am. Soc. Exp. Biol. 34, 591.
8. Calwell, J. L., Severson, C. D., & Thompson, J. S. (1973) Fed. Proc., Fed. Am. Soc. Exp. Biol. 32, 979.
9. Chen, R. F. (1967) J. Biol. Chem. 242, 173-181.
10. Foster, J. F. (1977) in Albumin Structure, Function and Uses (Rosenoer, V. M., Oratz, M., & Rothshild, M. A., Eds.) pp 53-84. Pergamon Press, Oxford, England.
11. Gurd, F. R. N., & Wilcox, P. E. (1956) Adv. Protein Chem. 11, 311-427.
12. He, X. M., & Carter, D. C. (1992) Nature 358, 209-211.
13. Hsia, J. C., Er, J. S., Tan, C. T., Ester, T., & Ruoslahti, E. (1980) J. Biol. Chem. 255, 4224-4227.
14. Jacobsen, J. (1977) Int. J. Pept. Protein Res. 9, 235-239.
15. Jaenike, L. (1974) Anal. Biochem. 61, 623-627.
16. King, T. P., & Spencer, E. M. (1972) Arch. Biochem. Bioophys. 153, 627-640.
17. Klopfenstein, W. F. (1969) Biochim. Biophys. Acta 187, 272-274.
18. Kragh-Hansen, U. (1981) Pharmacol. Rev. 33, 17-52.
19. Lange, P. H. (1983) in Onco-developmental markers: Biological, diagnosis and monitoring aspects (Fishman, W. H., Ed.) pp 241-255, Academic Press, New York.
20. Leybman, D. Ya., Tiktopulo, E. I., & Privalov, P. L. (1975) Biophysics (Moscow) 20, 376-379.
21. Lu, C. Y., Changelian, P. S., & Unanue, E. R. (1984) J. Immunol. 132, 1722-1727.
22. Morinaga, T., Sakai, M., Wegmann, G., & Tamaoki, T. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 4604-4608.
23. Nagai, M., Becker, J. D., & Deutsch, H. F. (1982) Oncodev. Biol. Med. 3, 343-350.
24. Nandedkar, A. K., Nurse, C. E., & Friedbreg, F. (1973) Int. J. Pept. Protein Res. 5, 279-281.
25. Nishi, S., Matsue, H., Yoshida, H., Yamamoto, R., & Sakai, M. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 3102-3105.
26. Oliviery, J. R., & Craievich, A. F. (1995) Eur. Biophys. J. 24, 77-84.
27. Parmelee, D. C., Evenson, M. A., & Deutsch, H. F. (1978) J. Biol. Chem. 253, 2114-2119.
28. Pearlman, W. F., & Crepy, O. (1967) J. Biol. Chem. 242, 182-189.
29. Pedersen, K. (1978) Scand. J. Clin. Lab. Invest. 38, 659-667.
30. Peters, T., Jr. (1985) Adv. Protein Chem. 37, 161-245.
31. Privalov, P. L. (1979) Adv. Protein Chem. 33, 167-244.
32. Privalov, P. L. (1982) Adv. Protein Chem. 35, 1-104.
33. Privalov, P. L., & Potekhin, S. A. (1986) Methods Enzymol. 131, 4-51.
34. Ptitsyn, O. B. (1995) Adv. Protein Chem. 47, 83-229.
35. Purves, L. R., Vender, M., & Bersohn, I. (1970) Lancet 2, 464-465.
36. Purves, L. R., Bersohn, I., & Geddes, E. W. (1978) Cancer 25, 1261-1270.
37. Roda, A., Cappelleri, G., Clute, O. L., & Peters, T., Jr. (1982) J. Lipid Res. 23, 490-495.
38. Ruoslahti, E., & Seppala, M. (1979) Adv. Cancer Res. 29, 275-346.
39. Ruoslahti, E., Ester, T., & Seppala, M. (1979) Biochim. Biophys. Acta 578, 511-519.
40. Sarkar, B. (1983) Life Chem. Rep. 1, 165-207.
41. Savu, L., Benassasyag, C., Vallette, G., Christeff N., & Nuney, E. (1981) J. Biol. Chem. 256, 9414-9418.
42. Seppala, M. (1975) Ann. N.Y. Acad. Sci. 259, 59-73.
43. Smith, J. P., & Kelleher, P. C. (1980) Biochim. Biophys. Acta 605, 1-32.
44. Smuckler, E. A., Koplitz, M., & Sell, S. (1976) Cancer Res. 36, 4558-4561.
45. Sogami, M., & Foster, J. F. (1968) Biochemistry 7, 2172-2182.
46. Sollene, N. P., Wu, H.-L., & Means, G. E. (1981) Arch. Biochem. Biophys. 207, 264-269.
47. Soloff, M. S., Swartz, S. K., Pearlmutter, F., & Kithier, K. (1972). Biochim. Biophys. Acta 427, 644-651.
48. Spector, A. A., & Fletcher, J. E. (1978) in Disturbance in Lipid and Lipoprotein Metabolism, pp 229-248, American Physiology Society, Rockville, MD.
49. Stryer, L. (1968) Science 162, 526-540.
50. Tomashevski, A. Yu., & Uversky, V. N. (1997) Russ. J. Bioorg. Chem. 23, in press.
51. Torres, J. M., Laborda, J., Naval, J., Darracq, N., Calvo, M., Mishal, Z., & Uriel, J. (1989) Mol. Immunol. 26, 851-857.
52. Unger, W. G. (1972) J. Pharm. Pharmacol. 24, 470-477.
53. Uriel, J., de Nechaud, B., & Dupiers, M. (1972) Biochem. Biophys. Res. Commun. 46, 1175-1180.
54. Uversky, V. N., Kirkitadze, M. D., Narizhneva, N. V., Potekhin, S. A., & Tomashevski, A. Yu. (1995) FEBS Lett. 364, 165-167.
55. Uversky, V. N., Narizhneva, N. V., Ivanova, T. V., Kirkitadze, M. D., & Tomashevski, A. Yu. (1997) FEBS Lett. 410, 280-284.
56. Wallevik, K. (1973) J. Biol. Chem. 248, 2650-2655.